Activity and unexpected lung toxicity of the sequential administration of two alkylating agents—Dacarbazine and fotemustine—in patients with melanoma

This publication has 25 references indexed in Scilit:

• Sequential administration of dacarbazine and fotemustine in patients with disseminated malignant melanoma—an effective combination with unexpected toxicity
  European Journal Of Cancer, 1992
• Final report of the french multicenter phase II study of the nitrosourea fotemustine in 153 evaluable patients with disseminated malignant melanoma including patients with cerebral metastases
  Cancer, 1990
• Combination chemotherapy of dacarbazine and fotemustine in disseminated malignant melanoma
  Cancer Chemotherapy and Pharmacology, 1990
• Inhibition of the hepatic o6-alkylguanine-DNA alkyltransferase in vivo by pretreatment with antineoplastic agents
  Biochemical Pharmacology, 1989
• Importance of the DNA repair enzyme O6-alkyl guanine alkyltransferase (AT) in cancer chemotherapy
  Cancer Treatment Reviews, 1988
• Nitrosourea derivatives-induced pulmonary toxicity in patients treated for malignant brain tumors. Early subclinical detection and its prevention
  European Journal of Cancer and Clinical Oncology, 1987
• Increased repair of O⁶-alkylguanine DNA adducts in glioma-derived human cells resistant to the cytotoxic and cytogenetic effects of 1, 3-bis(2-chloroethyl)-1-nitrosourea
  Carcinogenesis: Integrative Cancer Research, 1986
• Correlation between O⁶-methylguanine-DNA-methyltransferase activity and resistance of human cells to the cytotoxic and mutagenic effect of N-methyl-N′-nitro-N-nitrosoguanidine
  Carcinogenesis: Integrative Cancer Research, 1984
• The nitrosoureas and pulmonary toxicity
  Cancer Treatment Reviews, 1981
• DNA cross-linking and monoadduct repair in nitrosourea-treated human tumour cells
  Nature, 1980